Tags

Type your tag names separated by a space and hit enter

Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients.
Eur Urol 2003; 44(4):467-74EU

Abstract

OBJECTIVE

The present study was performed to examine the efficacy of a selective treatment according to the guidelines for the prevention of recurrence in calcium oxalate stone patients and to assess risk factors for stone recurrence.

METHODS

To investigate the effect of specific diagnostic and therapeutic measures, 134 recurrent calcium oxalate stone formers participated in a prospective study for two years with regular follow-ups of at least every six months. Depending on the results of analysis of 24-hour urine, nutrition record and metabolic situation, selective recommendations were given concerning diet and medication.

RESULTS

Throughout the follow-up period, 57 (43%) of the patients experienced relapses. In recurrence-free patients, the significant increase in urinary volume, as well as urinary pH, potassium and citrate excretion, three indexes of compliance with alkalization, resulted in a significant decrease in the calculated risk of calcium oxalate stone formation. In patients with recurrences during follow-up, the relative supersaturation with calcium oxalate increased significantly, mainly due to the significant rise in urinary oxalate excretion exceeding the significant increases in urinary volume, pH, potassium and citrate excretion. Multiple logistic regression analysis revealed previous ESWL treatment and a history of multiple stones as independent predictors of the risk for recurrence.

CONCLUSIONS

The results indicate that compliance with drinking advice and alkalization therapy was highest among both, patients with and without recurrences, compared with all other therapeutic measures. The increase in oxalate excretion is identified as the major urinary risk factor for relapse during follow-up in recurrent calcium oxalate stone disease.

Authors+Show Affiliations

Department of Urology, University of Bonn, Sigmund-Freud-Str 25, D-53105 Bonn, Germany. roswitha.siener@ukb.uni-bonn.deNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

14499683

Citation

Siener, Roswitha, et al. "Prospective Study On the Efficacy of a Selective Treatment and Risk Factors for Relapse in Recurrent Calcium Oxalate Stone Patients." European Urology, vol. 44, no. 4, 2003, pp. 467-74.
Siener R, Glatz S, Nicolay C, et al. Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. Eur Urol. 2003;44(4):467-74.
Siener, R., Glatz, S., Nicolay, C., & Hesse, A. (2003). Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. European Urology, 44(4), pp. 467-74.
Siener R, et al. Prospective Study On the Efficacy of a Selective Treatment and Risk Factors for Relapse in Recurrent Calcium Oxalate Stone Patients. Eur Urol. 2003;44(4):467-74. PubMed PMID: 14499683.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. AU - Siener,Roswitha, AU - Glatz,Sara, AU - Nicolay,Claudia, AU - Hesse,Albrecht, PY - 2003/9/23/pubmed PY - 2004/2/27/medline PY - 2003/9/23/entrez SP - 467 EP - 74 JF - European urology JO - Eur. Urol. VL - 44 IS - 4 N2 - OBJECTIVE: The present study was performed to examine the efficacy of a selective treatment according to the guidelines for the prevention of recurrence in calcium oxalate stone patients and to assess risk factors for stone recurrence. METHODS: To investigate the effect of specific diagnostic and therapeutic measures, 134 recurrent calcium oxalate stone formers participated in a prospective study for two years with regular follow-ups of at least every six months. Depending on the results of analysis of 24-hour urine, nutrition record and metabolic situation, selective recommendations were given concerning diet and medication. RESULTS: Throughout the follow-up period, 57 (43%) of the patients experienced relapses. In recurrence-free patients, the significant increase in urinary volume, as well as urinary pH, potassium and citrate excretion, three indexes of compliance with alkalization, resulted in a significant decrease in the calculated risk of calcium oxalate stone formation. In patients with recurrences during follow-up, the relative supersaturation with calcium oxalate increased significantly, mainly due to the significant rise in urinary oxalate excretion exceeding the significant increases in urinary volume, pH, potassium and citrate excretion. Multiple logistic regression analysis revealed previous ESWL treatment and a history of multiple stones as independent predictors of the risk for recurrence. CONCLUSIONS: The results indicate that compliance with drinking advice and alkalization therapy was highest among both, patients with and without recurrences, compared with all other therapeutic measures. The increase in oxalate excretion is identified as the major urinary risk factor for relapse during follow-up in recurrent calcium oxalate stone disease. SN - 0302-2838 UR - https://www.unboundmedicine.com/medline/citation/14499683/Prospective_study_on_the_efficacy_of_a_selective_treatment_and_risk_factors_for_relapse_in_recurrent_calcium_oxalate_stone_patients_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0302283803003178 DB - PRIME DP - Unbound Medicine ER -